This information is designed for educational purposes only and should not be used in any other manner. This information is not intended to substitute for informed medical advice. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified health care provider. A consultation with your health care professional is the proper method to address your health concerns. You are encouraged to consult your health care provider with any questions or concerns you may have regarding your condition. Rapid advances in medicine may cause information contained here to become outdated, invalid or subject to debate. Accuracy cannot be guaranteed.
Heath Canada Alerts
OTTAWA – The Government of Canada is committed to informing Canadians about the risks of health products that contain opioids. As a result, Health Canada is advising Canadians that people under 18 years of age should not use non-prescription pain relief products containing codeine. Non-prescription codeine-containing pain relief products were previously not recommended for children and youth under 12 years of age.
July 28, 2020 For immediate release
Health Canada is providing an update on the status of ranitidine drugs in Canada, including enhanced safety measures the Department is putting in place to detect an impurity called N-nitrosodimethylamine (NDMA).